117 related articles for article (PubMed ID: 21315702)
1. Prognostic cytokine markers in peripheral blood for oral cavity squamous cell carcinoma identified by multiplexed immunobead-based profiling.
Chang KP; Chang YT; Liao CT; Yen TC; Chen IH; Chang YL; Liu YL; Chang YS; Yu JS; Wu CC
Clin Chim Acta; 2011 May; 412(11-12):980-7. PubMed ID: 21315702
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of chemokine (C-X-C motif) ligand 9 (CXCL9) are associated with tumor progression and treatment outcome in patients with oral cavity squamous cell carcinoma.
Chang KP; Wu CC; Fang KH; Tsai CY; Chang YL; Liu SC; Kao HK
Oral Oncol; 2013 Aug; 49(8):802-7. PubMed ID: 23769451
[TBL] [Abstract][Full Text] [Related]
3. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
Shang ZJ; Li JR; Li ZB
Int J Oral Maxillofac Surg; 2002 Oct; 31(5):495-8. PubMed ID: 12418564
[TBL] [Abstract][Full Text] [Related]
4. Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling.
Linkov F; Lisovich A; Yurkovetsky Z; Marrangoni A; Velikokhatnaya L; Nolen B; Winans M; Bigbee W; Siegfried J; Lokshin A; Ferris RL
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):102-7. PubMed ID: 17220337
[TBL] [Abstract][Full Text] [Related]
5. Detection of serum Cyfra 21-1 in patients with primary oral squamous cell carcinoma.
Zhong LP; Zhu HG; Zhang CP; Chen WT; Zhang ZY
Int J Oral Maxillofac Surg; 2007 Mar; 36(3):230-4. PubMed ID: 16965897
[TBL] [Abstract][Full Text] [Related]
6. Can quantifying free-circulating DNA be a diagnostic and prognostic marker in oral epithelial dysplasia and oral squamous cell carcinoma?
Shukla D; Kale AD; Hallikerimath S; Yerramalla V; Subbiah V
J Oral Maxillofac Surg; 2013 Feb; 71(2):414-8. PubMed ID: 22749518
[TBL] [Abstract][Full Text] [Related]
7. Proinflammatory cytokines as serum biomarker in oral carcinoma-A prospective multi-biomarker approach.
Schiegnitz E; Kämmerer PW; Schön H; Blatt S; Berres M; Sagheb K; Al-Nawas B
J Oral Pathol Med; 2018 Mar; 47(3):268-274. PubMed ID: 29272054
[TBL] [Abstract][Full Text] [Related]
8. GDF 15 as an anti-apoptotic, diagnostic and prognostic marker in oral squamous cell carcinoma.
Schiegnitz E; Kämmerer PW; Koch FP; Krüger M; Berres M; Al-Nawas B
Oral Oncol; 2012 Jul; 48(7):608-14. PubMed ID: 22341306
[TBL] [Abstract][Full Text] [Related]
9. Galectin-1 and galectin-3: plausible tumour markers for oral squamous cell carcinoma and suitable targets for screening high-risk population.
Aggarwal S; Sharma SC; Das SN
Clin Chim Acta; 2015 Mar; 442():13-21. PubMed ID: 25578395
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients.
Chen CH; Lin YS; Lin CC; Yang YH; Ho YP; Tsai CC
J Oral Pathol Med; 2004 Nov; 33(10):589-94. PubMed ID: 15482324
[TBL] [Abstract][Full Text] [Related]
11. Proteomics-based identification of haptoglobin as a novel plasma biomarker in oral squamous cell carcinoma.
Lai CH; Chang NW; Lin CF; Lin CD; Lin YJ; Wan L; Sheu JJ; Chen SY; Huang YP; Sing YT; Tao TW; Lai CK; Tsai MH; Chan HL; Jou YJ; Lin CW
Clin Chim Acta; 2010 Jul; 411(13-14):984-91. PubMed ID: 20359475
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment interleukin-6 serum levels are associated with patient survival for oral cavity squamous cell carcinoma.
Chang KP; Kao HK; Wu CC; Fang KH; Chang YL; Huang YC; Liu SC; Cheng MH
Otolaryngol Head Neck Surg; 2013 May; 148(5):786-91. PubMed ID: 23426713
[TBL] [Abstract][Full Text] [Related]
13. Expression of vascular endothelial growth factor-C does not predict occult lymph-node metastasis in early oral squamous cell carcinoma.
Faustino SE; Oliveira DT; Nonogaki S; Landman G; Carvalho AL; Kowalski LP
Int J Oral Maxillofac Surg; 2008 Apr; 37(4):372-8. PubMed ID: 18295452
[TBL] [Abstract][Full Text] [Related]
14. Association between soluble MICA levels and disease stage IV oral squamous cell carcinoma in Japanese patients.
Tamaki S; Sanefuzi N; Kawakami M; Aoki K; Imai Y; Yamanaka Y; Yamamoto K; Ishitani A; Hatake K; Kirita T
Hum Immunol; 2008 Feb; 69(2):88-93. PubMed ID: 18361932
[TBL] [Abstract][Full Text] [Related]
15. NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma.
Rhodus NL; Ho V; Miller CS; Myers S; Ondrey F
Cancer Detect Prev; 2005; 29(1):42-5. PubMed ID: 15734216
[TBL] [Abstract][Full Text] [Related]
16. Cytokines and tumor markers in potentially malignant disorders and oral squamous cell carcinoma: a pilot study.
Czerninski R; Basile JR; Kartin-Gabay T; Laviv A; Barak V
Oral Dis; 2014 Jul; 20(5):477-81. PubMed ID: 23859102
[TBL] [Abstract][Full Text] [Related]
17. Elevated level of serum growth differentiation factor 15 is associated with oral leukoplakia and oral squamous cell carcinoma.
Yang CZ; Ma J; Luo QQ; Neskey DM; Zhu DW; Liu Y; Myers JN; Zhang CP; Zhang ZY; Zhong LP
J Oral Pathol Med; 2014 Jan; 43(1):28-34. PubMed ID: 23710769
[TBL] [Abstract][Full Text] [Related]
18. Serum soluble CD44v6 levels in patients with oral and maxillofacial malignancy.
Chang SM; Xing RD; Zhang FM; Duan YQ
Oral Dis; 2009 Nov; 15(8):570-2. PubMed ID: 19563418
[TBL] [Abstract][Full Text] [Related]
19. The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma.
Reichert TE; Scheuer C; Day R; Wagner W; Whiteside TL
Cancer; 2001 Jun; 91(11):2136-47. PubMed ID: 11391595
[TBL] [Abstract][Full Text] [Related]
20. Salivary zinc finger protein 510 peptide as a novel biomarker for detection of oral squamous cell carcinoma in early stages.
Jou YJ; Lin CD; Lai CH; Tang CH; Huang SH; Tsai MH; Chen SY; Kao JY; Lin CW
Clin Chim Acta; 2011 Jul; 412(15-16):1357-65. PubMed ID: 21497587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
